Compare OPK & CINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OPK | CINT |
|---|---|---|
| Founded | 2006 | 1995 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 921.2M | 646.9M |
| IPO Year | 2011 | 2021 |
| Metric | OPK | CINT |
|---|---|---|
| Price | $1.12 | $4.14 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | $1.60 | ★ $7.35 |
| AVG Volume (30 Days) | ★ 2.1M | 87.8K |
| Earning Date | 04-28-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $606,879,000.00 | N/A |
| Revenue This Year | N/A | $16.69 |
| Revenue Next Year | $4.24 | $11.28 |
| P/E Ratio | ★ N/A | $17.94 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.98 | $3.98 |
| 52 Week High | $1.60 | $6.71 |
| Indicator | OPK | CINT |
|---|---|---|
| Relative Strength Index (RSI) | 37.05 | 33.31 |
| Support Level | N/A | $4.03 |
| Resistance Level | $1.25 | $5.01 |
| Average True Range (ATR) | 0.05 | 0.23 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 48.78 | 12.78 |
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
CI&T Inc operates as a partner in tech-integrated business solutions, helping organizations address complex challenges by integrating business approach, technology, and artificial intelligence into a single, coherent operating model. It is mainly engaged in the development of customizable software through the implementation of software solutions, including machine learning, artificial intelligence, data analytics, cloud migration and mobility technologies. The company provides technology services to various industry verticals, including Financial Services, Consumer Goods, Technology and Communications, Retail and Industrial Goods, Life Sciences, among others. The majority of the revenue is derived from providing technology services. Geographically, maximum revenue is derived from Brazil.